About Solve Therapeutics
Solve Therapeutics is a private company based in Belmont, California, incorporated in 2021 in Delaware. It has reported $162,113,624 raised in three offerings on Form D since January 2022. Its chief executive is David Johnson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Nov 25, 2025 | $48,214,232of $120.5M target | 16 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Dec 13, 2024 | Dec 26, 2024 | $50,388,557of $75.5M target | 10 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Dec 17, 2021 | Jan 21, 2022 | $63,510,835of $126.5M target | 11 | $5.7M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $162,113,624 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Solve Therapeutics's Form D filed Nov 25, 2025.
DM
Daniel McHugh
Director
LM
Langdon Miller
Executive officer
DJ
David Johnson
Chief Executive Officer and director
CK
Clayton Knox
Executive officer
RM
Robert Mittendorff
Director
AC
Alan Colowick
Director
JP
Jason Pitts
Director
PC
Peter Colabuono
Director